PE firm sells German ophthalmology group for 3.6 times return — 4 insights

Private equity firm Palamon Capital Partners sold its stake in Furth, Germany-based ophthalmology group Ober Scharrer for 3.6 times its initial investment, Private Equity News reports.

Here's what you should know.

1. Palamon acquired a majority stake in the 80-clinic ophthalmology practice in 2011.

2. The clinic employs approximately 900 people and provides more than 85,000 treatments annually.

3. Palamon didn't disclose the transactions' exact financial figures.

4. A Palamon spokesperson said, "Robust demand driven by an ageing population and a number of add-ons [and] acquisitions have helped Ober triple its revenue, earnings and number of clinics since 2011."

More articles on transactions/valuations: 
UnitedHealth Group eyes 2nd ambulatory acquisition & more — 9 ASC company key notes
6 things to know about IBS
Oregon House passes extended recovery stay bill, allows ASC patients to stay 48 hours

© Copyright ASC COMMUNICATIONS 2018. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Top 40 Articles from the Past 6 Months